Ohio Medicaid Drug Lives by Payer and PBM, as of March 2021

Ohio’s 2.4 million Medicaid drug lives are currently managed by five PBMs, which contract with both the state and its managed care plans. Gainwell Technologies will take over as the state’s single PBM in 2022, the beginning of a 7.5-year contract. Ohio is also rebidding its Medicaid managed care contracts for 2022, but it’s unclear when awards will be unveiled.

SOURCE: MMIT Analytics as of 3/30/21.

AIS Health Staff

AIS Health Staff

Related Posts

businessmen-shaking-hands
September 21

McClellan: IRA Price Negotiations May Have Broader Impact Beyond Drugs on List

Read More
iv-therapy
September 21

FDA Approves First Multiple Sclerosis Biosimilar, Sandoz’s Tyruko

Read More
businesswoman-using-tablet
September 21

Now That Humira Biosimilars Have Launched, What Are Lessons Learned for Stelara Biosimilars?

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today